MedKoo Cat#: 581560 | Name: Deacetyl acebutolol

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Deacetyl acebutolol also known as acebutolol. It is a Cardioselective Beta Blocker, Promotes Glucose Uptake in Diabetic Model Cells by Inhibiting JNK-JIP1 Interaction.

Chemical Structure

Deacetyl acebutolol
Deacetyl acebutolol
CAS#27783-53-5

Theoretical Analysis

MedKoo Cat#: 581560

Name: Deacetyl acebutolol

CAS#: 27783-53-5

Chemical Formula: C16H26N2O3

Exact Mass: 294.1943

Molecular Weight: 294.40

Elemental Analysis: C, 65.28; H, 8.90; N, 9.52; O, 16.30

Price and Availability

This product was removed for the commercial reasons.
Related CAS #
No Data
Synonym
Deacetyl acebutolol; Acetutolol;
IUPAC/Chemical Name
Butanamide, N-(4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-
InChi Key
SZQPDJRQGAJVTI-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H26N2O3/c1-4-5-16(20)18-13-6-8-15(9-7-13)21-11-14(19)10-17-12(2)3/h6-9,12,14,17,19H,4-5,10-11H2,1-3H3,(H,18,20)
SMILES Code
CCCC(NC1=CC=C(OCC(O)CNC(C)C)C=C1)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 294.40 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Cui C, Huang C, Liu K, Xu G, Yang J, Zhou Y, Feng Y, Kararigas G, Geng B, Cui Q. Large-scale in silico identification of drugs exerting sex-specific effects in the heart. J Transl Med. 2018 Aug 29;16(1):236. doi: 10.1186/s12967-018-1612-6. PubMed PMID: 30157868; PubMed Central PMCID: PMC6116388. 2: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501141/ PubMed PMID: 30000200. 3: Tucker WD, Theetha Kariyanna P. Selective Beta-1-Blockers. 2018 Oct 5. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK499982/ PubMed PMID: 29763157. 4: Nsubuga H, Basheer C, Haider MB, Bakdash R. Sol-gel based biogenic silica composite as green nanosorbent for chemometric optimization of micro-solid-phase extraction of beta blockers. J Chromatogr A. 2018 Jun 15;1554:16-27. doi: 10.1016/j.chroma.2018.04.044. Epub 2018 Apr 21. PubMed PMID: 29705646. 5: Li Y, Jung NY, Yoo JC, Kim Y, Yi GS. Acebutolol, a Cardioselective Beta Blocker, Promotes Glucose Uptake in Diabetic Model Cells by Inhibiting JNK-JIP1 Interaction. Biomol Ther (Seoul). 2018 Sep 1;26(5):458-463. doi: 10.4062/biomolther.2017.123. PubMed PMID: 29129046; PubMed Central PMCID: PMC6131017. 6: K R, V S. Discovery of Potent Neuraminidase Inhibitors Using a Combination of Pharmacophore-Based Virtual Screening and Molecular Simulation Approach. Appl Biochem Biotechnol. 2018 Apr;184(4):1421-1440. doi: 10.1007/s12010-017-2625-y. Epub 2017 Oct 23. PubMed PMID: 29063410. 7: Cheung SYA, Rodgers T, Aarons L, Gueorguieva I, Dickinson GL, Murby S, Brown C, Collins B, Rowland M. Whole body physiologically based modelling of β-blockers in the rat: events in tissues and plasma following an i.v. bolus dose. Br J Pharmacol. 2018 Jan;175(1):67-83. doi: 10.1111/bph.14071. Epub 2017 Dec 1. PubMed PMID: 29053169; PubMed Central PMCID: PMC5740248. 8: Szultka-Młyńska M, Bajkacz S, Baranowska I, Buszewski B. Structural characterization of electrochemically and in vivo generated potential metabolites of selected cardiovascular drugs by EC-UHPLC/ESI-MS using an experimental design approach. Talanta. 2018 Jan 1;176:262-276. doi: 10.1016/j.talanta.2017.08.041. Epub 2017 Aug 15. PubMed PMID: 28917751. 9: Wojnarowska Z, Rams-Baron M, Knapik-Kowalczuk J, Połatyńska A, Pochylski M, Gapinski J, Patkowski A, Wlodarczyk P, Paluch M. Experimental evidence of high pressure decoupling between charge transport and structural dynamics in a protic ionic glass-former. Sci Rep. 2017 Aug 1;7(1):7084. doi: 10.1038/s41598-017-07136-5. PubMed PMID: 28765639; PubMed Central PMCID: PMC5539233. 10: Salem AA, Wasfi I, Al-Nassib SS, Allawy Mohsin M, Al-Katheeri N. Determination of Some β-Blockers and β2-Agonists in Plasma and Urine Using Liquid Chromatography-tandem Mass Spectrometry and Solid Phase Extraction. J Chromatogr Sci. 2017 Sep 1;55(8):846-856. doi: 10.1093/chromsci/bmx045. PubMed PMID: 28633284. 11: Carda-Broch S, García-Alvarez-Coque MC, Ruiz-Angel MJ. Extent of the influence of phosphate buffer and ionic liquids on the reduction of the silanol effect in a C18 stationary phase. J Chromatogr A. 2018 Jul 20;1559:112-117. doi: 10.1016/j.chroma.2017.05.061. Epub 2017 Jun 1. PubMed PMID: 28602502. 12: Shimamoto S, Ijiri D, Kawaguchi M, Nakashima K, Tada O, Inoue H, Ohtsuka A. β(1)- and β(2)-adrenergic receptor stimulation differ in their effects on PGC-1α and atrogin-1/MAFbx gene expression in chick skeletal muscle. Comp Biochem Physiol A Mol Integr Physiol. 2017 Sep;211:1-6. doi: 10.1016/j.cbpa.2017.05.013. Epub 2017 Jun 1. PubMed PMID: 28578076. 13: Tomková J, Ondra P, Kocianová E, Václavík J. Fast and sensitive analysis of beta blockers by ultra-high-performance liquid chromatography coupled with ultra-high-resolution TOF mass spectrometry. Biomed Chromatogr. 2017 Jul;31(7). doi: 10.1002/bmc.3911. Epub 2017 Jan 4. PubMed PMID: 27925253. 14: Talmaciu MM, Bodoki E, Oprean R. Global chemical reactivity parameters for several chiral beta-blockers from the Density Functional Theory viewpoint. Clujul Med. 2016;89(4):513-518. Epub 2016 Oct 20. PubMed PMID: 27857521; PubMed Central PMCID: PMC5111492. 15: Sun L, Sun J, He Z. Exploring the Feasibility of Biowaiver Extension of BCS Class III Drugs with Site-Specific Absorption Using Gastrointestinal Simulation Technology. Eur J Drug Metab Pharmacokinet. 2017 Jun;42(3):471-487. doi: 10.1007/s13318-016-0361-2. PubMed PMID: 27447171. 16: Bruchatá K, Némethy A, Čižmáriková R, Račanská E, Habala L. Synthesis and In Vitro Pharmacological Evaluation of 5-(Alkoxymethyl)-2-(3-alkylamino-2-hydroxypropoxy)phenylethanones Related to Acebutolol and Celiprolol. Arch Pharm (Weinheim). 2016 Sep;349(9):733-40. doi: 10.1002/ardp.201600136. Epub 2016 Jul 15. PubMed PMID: 27417385. 17: Veinberg SL, Johnston KE, Jaroszewicz MJ, Kispal BM, Mireault CR, Kobayashi T, Pruski M, Schurko RW. Natural abundance (14)N and (15)N solid-state NMR of pharmaceuticals and their polymorphs. Phys Chem Chem Phys. 2016 Jun 29;18(26):17713-30. doi: 10.1039/c6cp02855a. PubMed PMID: 27314503. 18: Sanganyado E, Fu Q, Gan J. Enantiomeric selectivity in adsorption of chiral β-blockers on sludge. Environ Pollut. 2016 Jul;214:787-794. doi: 10.1016/j.envpol.2016.04.091. Epub 2016 May 4. PubMed PMID: 27155096. 19: Khouri C, Jouve T, Blaise S, Carpentier P, Cracowski JL, Roustit M. Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis. Br J Clin Pharmacol. 2016 Aug;82(2):549-60. doi: 10.1111/bcp.12980. Epub 2016 May 31. Review. PubMed PMID: 27085011; PubMed Central PMCID: PMC4972171. 20: Goryński K, Kiedrowicz A, Bojko B. Development of SPME-LC-MS method for screening of eight beta-blockers and bronchodilators in plasma and urine samples. J Pharm Biomed Anal. 2016 Aug 5;127:147-55. doi: 10.1016/j.jpba.2016.03.001. Epub 2016 Mar 4. PubMed PMID: 26971030.